The Convention on Pharmaceutical Ingredients for Southeast Asia (CPhI SEA) exhibition held in Jakarta from April 6 to 8 provided an excellent opportunity for Monroe Consulting Group Indonesia’s recruitment consultants to take the pulse of the jobs markets and overall human resources sectors within the industry.
About 6,000 visitors attended the event, which featured more than 200 participants from 25 countries and was designed to provide unrivalled access to international networks and information and enhance business opportunities within the pharmaceutical industry within the Association of Southeast Asian Nations (Asean).
Irma Lovenia Promono, a recruitment consultant from Monroe Indonesia’s specialised Industrial Division, said it was crucial that the Company remained up-to-date on the latest market trends and knowledge that would ensure that it was best able to service its multinational and national clients operating within the dynamic growth industry.
“Moreover, attending international events like CPhI is one of our key strategies to remain in close contact with industry experts and senior executives, which allows us best understand a particular company’s plans within Indonesia or the region to determine how Monroe can best help them acquire the right talent to achieve their business objectives,” she said.
The fifth CPhI SEA featured four events, including the International Contract Services Expo (ICSE), an exhibition on outsource and contract services, and Health Ingredients (Hi), an exhibition on ingredients for pharma food products with pharmacological additives intended to improve health. Other events included InnoPack, an exhibition on drug packaging and delivery systems, and P-MEC, an exhibition on machinery and equipment for manufacturing drugs.
Mukul Koli, a second Monroe recruitment consultant that attended the event, said he met with a number of C-level decision makers, many of whom expressed interest in establishing manufacturing operations in Indonesia but had been put off by strict regulations and burdensome government bureaucracy.
“A number of professionals also mentioned that the government must offer incentives plans and widen the door to foreign direct investment in the pharmaceutical industry to reduce dependence on imported raw materials,” Mr Koli said. “Many believe that Indonesia can become a production base for overseas manufacturers given its large market.”
Mr Koli said the scope of the convention was enormous, extending well beyond pharmaceutical manufacturing and raw materials companies. “There were other companies involved in packaging, delivery systems and machinery in support of the industry to name a few,” he said. “The opportunity to gain insights about the latest technology, innovations, trends and developments within Indonesia's developing market was invaluable.”